COVID-19 testing service now available from MDNA's UK laboratory: Click here ›

Month: December 2014

MDNA Life Sciences enters collaboration agreement with University of Cambridge to validate Mitochondrial Biomarker blood-based diagnostic for prostate cancer

The study will evaluate the Company’s novel mitochondrial DNA-based test for accurately identifying prostate cancer in blood samples from men with elevated PSA levels that are at risk for prostate cancer.

Continue reading “MDNA Life Sciences enters collaboration agreement with University of Cambridge to validate Mitochondrial Biomarker blood-based diagnostic for prostate cancer”